17/04/2014 23:02:26 Free Membership Login

Inovio News (AMEX:INO)

DateTimeSource
Headline
04/08/20141:01PMPRNUSActive Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma Editor Note: For more information about this release, please scroll to bottom PR Newswire LONDON, April 8, 2014 LONDON, April 8, 2014 /PRNewswire/ -- The trading session on Monday, April 07, 2014 ended on a lower... More...>>
04/01/20144:00AMPRNUSInovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality Immunotherapy and Vaccine Leader Also Promotes Three Executives in Legal, Clinical and Investor Relations PR Newswire BLUE BELL, Pa., April 1, 2014 BLUE BELL, Pa., April 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE... More...>>
03/26/20144:00AMPRNUSInovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014
Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014 Biotech Judged First-in-Class for Cervical Pre-Cancer Immunotherapy (VGX-3100), Which Reports Phase II Results Mid-year 2014 Also Awarded "Best Vaccine Licensing Deal" and "Best Early Stage Biotech"... More...>>
03/19/20148:00AMPRNUSEquities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco
Equities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco Editor Note: For more information about this release, please scroll to bottom. PR Newswire LONDON, March 19, 2014 LONDON, March 19, 2014 /PRNewswire/ -- The trading session on Tuesday, March 18, 2014 ended on a higher note... More...>>
03/17/20144:00AMPRNUSInovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results
Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results PR Newswire BLUE BELL, Pa., March 17, 2014 BLUE BELL, Pa., March 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total revenue... More...>>
03/12/20144:00AMPRNUSInovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014 PR Newswire BLUE BELL, Pa., March 12, 2014 BLUE BELL, Pa., March 12, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its... More...>>
03/04/20149:49AMPRNUSInovio Pharmaceuticals Closes $63.3 Million Underwritten Financing
Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing PR Newswire BLUE BELL, Pa., March 4, 2014 BLUE BELL, Pa., March 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of 21,810,900 shares of... More...>>
02/27/20149:00AMPRNUSInovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire BLUE BELL, Pa., Feb. 27, 2014 BLUE BELL, Pa., Feb. 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of 18,966,000 shares... More...>>
02/26/20144:01PMPRNUSInovio Pharmaceuticals Announces Public Offering of Common Stock
Inovio Pharmaceuticals Announces Public Offering of Common Stock PR Newswire BLUE BELL, Pa., Feb. 26, 2014 BLUE BELL, Pa., Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common stock in an underwritten... More...>>
02/26/20147:00AMPRNUSInovio's Revolutionary DNA Immunotherapy Product Slated for Trials in 2014, by BrokerBank Securities, Inc.
Inovio's Revolutionary DNA Immunotherapy Product Slated for Trials in 2014, by BrokerBank Securities, Inc. PR Newswire NEW YORK, Feb. 26, 2014 NEW YORK, Feb. 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals (NYSEMKT: INO) plans to put its HPV-related cancer and pre-cancer treatment, VGX-3100, through Phase II trials... More...>>
02/19/20144:00AMPRNUSInovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference
Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference PR Newswire BLUE BELL, Pa., Feb. 19, 2014 BLUE BELL, Pa., Feb. 19, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the... More...>>
02/18/20144:00AMPRNUSInovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immun...
Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies New VPs of R&D and Clinical Development add extensive pharmaceutical and biotech immunotherapy product development experience PR Newswire BLUE BELL, Pa., Feb. 18, 2014 BLUE BELL... More...>>
02/11/20144:00AMPRNUSInovio Pharmaceuticals Invited To Ring the Opening Bell® at the New York Stock Exchange on February 12
Inovio Pharmaceuticals Invited To Ring the Opening Bell® at the New York Stock Exchange on February 12 2014 Marks A Transformative Year for the Leader in DNA Vaccines and Cancer Immunotherapies PR Newswire BLUE BELL, Pa., Feb. 11, 2014 BLUE BELL, Pa., Feb. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT:... More...>>
01/30/20144:00AMPRNUSInovio Pharmaceuticals to Present at BIO CEO & Investor Conference
Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference PR Newswire BLUE BELL, Pa., Jan. 30, 2014 BLUE BELL, Pa., Jan. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the... More...>>
01/23/20144:00AMPRNUSInovio Pharmaceuticals Unveils Potent New Immune Activator
Inovio Pharmaceuticals Unveils Potent New Immune Activator Inovio develops DNA-based immune booster (IL-33) that enhances T-cell responses and generates effective CD8 mediated tumor regression New DNA-based cytokine adds to Inovio's portfolio of DNA-based immune activators that complement its DNA immunotherapies PR Newswire... More...>>
01/06/20144:00AMPRNUSInovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference PR Newswire BLUE BELL, Pa., Jan. 6, 2014 BLUE BELL, Pa., Jan. 6, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview of the company at... More...>>
12/11/20138:05AMPRNUSCEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel PR Newswire BLUE BELL, Pa., Dec. 11, 2013 BLUE BELL, Pa., Dec. 11, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate... More...>>
11/20/20133:05AMPRNUSInovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial No vaccine exists for the MERS virus that has killed 42% of those infected PR Newswire BLUE BELL, Pa., Nov. 20, 2013 BLUE BELL, Pa., Nov. 20, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO... More...>>
11/19/20134:00AMPRNUSInovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees PR Newswire BLUE BELL, Pa., Nov. 19, 2013 BLUE BELL, Pa., Nov. 19, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) reported that the International Vaccine Institute (IVI) appointed Inovio's President and CEO, Dr... More...>>
11/18/20138:00PMPRNUSInternational Vaccine Institute Announces Appointments of New Members to its Board of Trustees
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees Professor Fred Binka, Dr. Joseph J. Kim, and Dr. George R. Siber to join the International Vaccine Institute's Board PR Newswire SEOUL, South Korea, Nov. 18, 2013 SEOUL, South Korea, Nov. 18, 2013 /PRNewswire/ -- The International... More...>>


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ino140417 23:02